Myriad Genetics, Inc. (MYGN) Tops Q2 EPS by 4c, Boosts Guidance

February 5, 2013 4:31 PM

Myriad Genetics, Inc. (NASDAQ: MYGN) reported Q2 EPS of $0.42, $0.04 better than the analyst estimate of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found